Is TB-500 Legal in California? Federal Law, State Rules, and How to Get It Legally
See the public record for TB-500
At a glance
- FDA approval / Not approved; no USP or National Formulary monograph and no approved product in the countries FDA checked [1]
- Compounding lists / On neither FDA's list for state-licensed pharmacies and physicians nor the outsourcing facility list [2][3][4]
- Safety-risk page / In the 'nominated but withdrawn' table, not the active category 2 table [7]
- Advisory committee / Voted in favor of adding it on July 23, 2026; advice only [8][5]
- HHS draft policy / Draft enforcement discretion for certain TB-500 acetate injections [5][6]
- Human data / No study found in which TB-500 was given to a person [1]
- Sport / Prohibited at all times by WADA under S2.3 [9]
What federal rules apply to TB-500?
A state-licensed pharmacy or physician compounding under federal law may use a bulk substance only if it complies with a USP or National Formulary monograph, is a component of an FDA-approved drug, or appears on FDA's bulks list [4]. FDA found no USP or National Formulary monograph for TB-500 and no FDA-approved drug containing it [1]. TB-500 is not on the bulks list and appears in none of the three categories on FDA's lists for pharmacies and physicians or for outsourcing facilities [2][3][4]. State requirements may apply in addition to these federal rules.
Where TB-500 does appear in federal materials
TB-500 sits in the 'nominated but withdrawn' table on FDA's page for bulk substances that may present significant safety risks. That table holds substances previously in category 2 whose nominators withdrew them, and removal was not a finding that TB-500 is safe [7]. FDA's stated concerns are no human exposure data, missing safety information, and immunogenicity risk for injectable peptides from aggregation and peptide-related impurities [7].
FDA staff recommended against adding TB-500 to the bulks list. The Pharmacy Compounding Advisory Committee voted in favor on July 23, 2026, against that recommendation; the vote is advice only [1][8][5].
HHS's draft policy, filed October 28, 2026 as Federal Register document 2026-22192, names TB-500 among six peptides and covers the acetate form by subcutaneous or intramuscular injection [5][6]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with it when conditions such as a single active ingredient and a patient-specific prescription are met. The notice also says it 'does not establish any rights for any person and is not binding on HHS or the public' [5][6].
Do thymosin beta-4 studies apply to TB-500?
No. TB-500 is a synthetic 7-amino-acid fragment (residues 17 to 23, Ac-LKKTETQ) of the 43-amino-acid protein thymosin beta-4 [1]. FDA found no article in which TB-500 itself was given to a person [1]. Human studies of the full-length protein, such as a phase 1 trial of intravenous recombinant thymosin beta-4 in healthy volunteers, do not show that TB-500 works or is safe [1][10].
TB-500 is also relevant to athletes. WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, in and out of competition [9][11].
Frequently asked questions
Is TB-500 legal in California?
Can a California pharmacy compound TB-500 on a prescription?
Did an FDA committee vote to add TB-500 to the bulks list?
References
Show all 11 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Official web page.
- Official web page.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Wang X, Liu L, Qi L, Lei C, Li P, Wang Y, et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. J Cell Mol Med. 2021;25(17):8222-8228.
- World Anti-Doping Agency.